BPC-157 Where To Inject For Shoulder

Shoulder Anatomy and Rotator Cuff Structure

The shoulder is the most mobile joint in the body, composed of the humerus (upper arm bone), scapula (shoulder blade), clavicle (collarbone), and surrounding muscles and tendons. The rotator cuff is a network of four muscles (supraspinatus, infraspinatus, teres minor, subscapularis) and their tendons that stabilize the humeral head in the glenoid socket. Rotator cuff injuries—including tears, tendinopathy, and impingement—are extremely common in athletes and aging populations, often causing chronic pain and reduced mobility.

BPC-157 has been studied for its capacity to promote collagen synthesis and tendon-bone healing, making targeted shoulder injection valuable for rotator cuff regeneration. Direct intramuscular injection into the rotator cuff muscles allows the peptide to reach tendinous insertion points, where healing is most critical.

Anatomical Landmarks for Shoulder Injection

Accurate shoulder injection requires understanding key bony landmarks. The acromion process—the bony prominence at the top of the shoulder—is the primary landmark for rotator cuff injection.

Key landmarks:

• Acromion process: Palpate the bony peak at the top of the shoulder. This landmark is the reference point for depth and positioning.
• Posterior shoulder: The infraspinatus muscle lies on the posterior aspect of the scapula, beneath the acromion. This is the most commonly targeted muscle for BPC-157 injection.
• Injection depth: The target is 2–3 cm below the acromion, in the infraspinatus muscle belly.
• Lateral reference: Position the injection 3–4 cm medial to the lateral shoulder edge to avoid hitting the deltoid anteriorly.

Infraspinatus Muscle Injection Technique

The infraspinatus muscle is the most commonly targeted rotator cuff muscle for BPC-157 injection because it is easily accessible, relatively large, and its tendon inserts directly on the humeral head at the site of common rotator cuff pathology.

Step-by-step injection procedure:

• Patient positioning: Position the patient seated, with the arm relaxed across the body or in the lap. This positioning opens the posterior shoulder and makes the infraspinatus more prominent and accessible.
• Landmark identification: Palpate the acromion process at the top of the shoulder with one hand.
• Mark the injection site: From the acromion, move 2–3 cm directly inferiorly (downward) and 3–4 cm medially (toward the spine) to mark the injection site. This positions you in the infraspinatus muscle belly.
• Cleanse the area: Use an alcohol pad in a circular motion for 30 seconds; allow to dry.
• Needle selection: Use a 22–25 gauge, 1.5" needle to ensure adequate penetration of the deltoid muscle and positioning in the infraspinatus.
• Insertion angle: Insert the needle at a 45–60 degree angle, aimed medially and slightly superiorly toward the scapula. This angle follows the muscle fiber direction and minimizes tissue disruption.
• Depth advancement: Advance 1.0–1.25" until you feel a slight change in resistance, indicating you've entered the infraspinatus muscle (deeper than the superficial deltoid).
• Aspiration test: Draw back on the plunger; confirm negative aspiration (no blood or fluid returns).
• Injection: Deliver the solution slowly over 5–10 seconds to allow dispersion through the muscle.
• Withdrawal and pressure: Remove the needle and apply gentle pressure with gauze for 15–20 seconds to minimize bleeding.

Proper positioning places the needle tip in the infraspinatus muscle, within 1–2 cm of the rotator cuff tendon insertion. The peptide diffuses from the muscle into the tendinous and periosteal tissue, achieving high local concentration.

Deltoid Region Injection and Rotator Cuff Access

Some practitioners use the anterior deltoid approach for shoulder injection, targeting the muscle anteriorly above the shoulder joint. While accessible, the anterior deltoid approach is further from the primary rotator cuff insertion sites. The posterior infraspinatus approach is generally preferred because the infraspinatus tendon directly inserts on the posterior humeral head, the primary site of rotator cuff tears.

The anterior approach (through the deltoid) can be useful for targeting anterior shoulder pathology (subscapularis tendinopathy, anterior capsular inflammation) but requires careful angle selection to avoid neurovascular structures in the anterior shoulder region.

AC Joint Proximity and Safe Needle Angulation

The acromioclavicular (AC) joint—where the acromion meets the clavicle—is located superiorly, just above the injection site. Excessive superior needle angulation (aiming too high toward the AC joint) risks intra-articular AC joint injection, which is not the intended target.

Safe positioning:

• Aim the needle downward (inferior) and medially (toward the spine), not upward. This angulation naturally avoids the AC joint.
• The AC joint is a small articulation with limited capacity; intra-articular injection here is less useful than periosteal or intramuscular injection.
• Confirm your injection site is at least 2–3 cm below the acromion to ensure you're well below the AC joint level.

Neurovascular Safety: Avoiding the Axillary Nerve

The axillary nerve is a critical structure that passes posteriorly through the shoulder, typically located 4–5 cm inferior to the acromion. Direct nerve injury from shoulder injection is rare when the proper depth is maintained (1.0–1.25"), but understanding the anatomy is essential for safety.

Critical safety points:

• Nerve location: The axillary nerve runs posterior and inferior to the rotator cuff, approximately 4–5 cm below the acromion. Standard intramuscular infraspinatus injection (1.0–1.25" depth) does not reach this depth in most individuals.
• Avoid excessive depth: Do not advance the needle beyond 1.25" or you risk contacting deeper structures.
• Posterolateral positioning: Position the injection posterolaterally (on the back and lateral edge of the shoulder). Avoid medial positioning toward the spine, which can increase axillary nerve contact risk.
• Pain during injection: If you feel sharp pain or tingling radiating down the arm during injection, stop immediately and withdraw. This suggests nerve contact; do not reattempt in the same location.

Subclavian vessels (located anterior and deep to the shoulder) are not at risk with posterior infraspinatus injection, as they are anterior and superior to the injection site.

Dosing and Cycling for Rotator Cuff Pathology

Standard protocols for BPC-157 shoulder injections:

• Dose: 250–500 mcg per injection (most common: 300–400 mcg for shoulder due to larger muscle mass)
• Frequency: 1–2 times weekly for acute rotator cuff tears; once weekly for chronic tendinopathy or maintenance
• Cycle length: 12–16 weeks for significant rotator cuff tears; 8–10 weeks for chronic tendinopathy without structural damage
• Rest periods: 4–6 weeks between cycles
• Route: Intramuscular injection into infraspinatus (or supraspinatus for superior pathology)

Rotator cuff injuries benefit from extended cycles because tendon-to-bone healing is slow, typically requiring 12+ weeks for structural maturation. Many practitioners combine shoulder BPC-157 injections with TB-500 for enhanced tissue regeneration.

Timeline of Rotator Cuff Healing Response

Healing progression in rotator cuff pathology:

• Weeks 1–4: Pain reduction and acute inflammatory resolution. Collagen synthesis begins. Motion may improve 10–20%.
• Weeks 5–8: Peak collagen deposition and cross-linking. Tendon tensile strength increases notably. Pain reduction becomes substantial (40–60%).
• Weeks 9–12: Continued tissue remodeling and maturation. Functional strength gains accelerate. Return to light activity becomes possible.
• Weeks 13–16: Complete tissue maturation (in most cases). Pain is minimal or resolved. Full functional capacity is achievable with appropriate rehabilitation.

Rehabilitation Integration for Shoulder Recovery

BPC-157 shoulder injection must be paired with progressive shoulder rehabilitation for optimal outcomes. The peptide creates a healing environment; targeted exercises provide the mechanical stimulus necessary for tissue adaptation.

Rehabilitation phases:

• Phase 1 (Weeks 1–3): Passive range of motion and pain control. Gentle pendulum exercises. Ice/heat therapy. Avoid active arm movement beyond pain-free range.
• Phase 2 (Weeks 4–8): Active range of motion exercises. Isometric rotator cuff strengthening (internal/external rotation). Begin light resistance training.
• Phase 3 (Weeks 9–12): Progressive resistance training (shoulder press, lateral raises, rows). Dynamic stability exercises. Sport-specific movement patterns at submaximal intensity.
• Phase 4 (Weeks 13+): Return to full activity. Continued maintenance strengthening to prevent recurrence.

Safety Considerations and Adverse Effects

Infraspinatus BPC-157 injection is well-tolerated. Reported adverse effects include:

• Transient local soreness or muscle ache at the injection site (resolves within 24–48 hours).
• Mild bruising from capillary contact (rare and cosmetic).
• Rare temporary increase in shoulder pain 12–24 hours post-injection (attributed to acute inflammatory response; resolves with ice and rest).
• No systemic adverse effects documented.

Contraindications include: active infection at the injection site, severe coagulopathy, allergy to peptide components, or pregnancy. Individuals with recent shoulder surgery (within 6 weeks) should obtain surgical clearance before injection.

Monitoring Progress and Treatment Adjustments

Track efficacy through:

• Pain assessment: Rate resting pain, motion-induced pain, and night pain weekly.
• Range of motion: Measure forward flexion, abduction, and internal/external rotation monthly (or weekly if progressing rapidly).
• Functional tests: Assess ability to reach overhead, lift the arm laterally, and rotate internally. Document specific activities that improve (e.g., throwing, swimming, overhead press).
• Strength testing: Use resistance bands to test rotator cuff strength; objective improvement indicates healing progression.

If minimal improvement after 8–10 weeks, consider: increasing frequency to twice weekly, extending cycle length to 20+ weeks, or adding TB-500. If strong improvement appears early, spacing injections to every 2 weeks is acceptable.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions

Q: Can I inject the supraspinatus directly?
A: Yes, the supraspinatus (the rotator cuff muscle above the spine of the scapula) can be targeted. The injection site is superior to the infraspinatus, approximately 1–2 cm superior to the acromion. The supraspinatus approach is useful for superior rotator cuff pathology or anterior shoulder impingement. However, the infraspinatus approach is generally easier and equally effective.

Q: How do I know if I've hit the axillary nerve?
A: Axillary nerve injury typically produces sharp pain or tingling that radiates down the arm, particularly in the lateral arm and shoulder region. If this occurs, withdraw the needle immediately and do not reinject. A single needle contact causes transient pain that resolves within minutes; seek emergency care only if pain is severe or persistent.

Q: Can I exercise immediately after a shoulder BPC-157 injection?
A: Light activity (walking) is fine immediately. Avoid shoulder-specific exercise for 48 hours post-injection to allow initial healing response. Resume graduated shoulder exercises per the rehabilitation timeline.

Q: Will BPC-157 allow me to avoid rotator cuff surgery?
A: BPC-157 may help resolve pain and improve function in partial rotator cuff tears and chronic tendinopathy. However, complete rotator cuff tears with significant retraction may require surgical repair regardless of peptide treatment. Use BPC-157 as a first-line therapeutic strategy; consult an orthopedic surgeon to determine surgical necessity.

Q: How long do rotator cuff healing effects last after stopping BPC-157?
A: Tissue healing induced by BPC-157 is permanent—the peptide accelerates your body's own repair mechanisms. After the cycle ends and tissue has matured (weeks 12–16), benefits are sustained as long as you maintain appropriate activity and avoid re-injury. Some practitioners repeat cycles yearly or every 18 months for prophylactic tissue maintenance.

Q: Can I combine bilateral shoulder injections in one session?
A: Yes, you can inject both shoulders in a single session if bilateral pathology exists. Space injections by 10–15 minutes to allow initial healing response between injections. This approach is useful for symmetrical rotator cuff tendinopathy.